XLRN · Acceleron Pharma Inc
Acquired Company
Merck completed the acquisition of Acceleron Pharma Inc. on 11/22/2021 for US $180 per share in cash, resulting in Acceleron becoming a wholly owned subsidiary of Merck.
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Market Cap
1.018B
52 Wk Range
N/A - N/A
Previous Close
$178.75
Open
$178.75
Volume
N/A
Day Range
$178.75 - $178.75
Enterprise Value
N/A
Cash
159.3M
Avg Qtr Burn
N/A
Insider Ownership
N/A
Institutional Own.
N/A
Qtr Updated
Mar 31st 2025